MedPath
FDA Approval

Ondansetron Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 29, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ondansetron(4 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

West-Ward Columbus Inc.

Hikma Pharmaceuticals USA Inc.

058839929

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ondansetron Hydrochloride

Product Details

NDC Product Code
0054-0064
Application Number
ANDA076960
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 4, 2016
Code: NMH84OZK2BClass: ACTIMQuantity: 4 mg in 5 mL
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
SACCHARIN SODIUM ANHYDROUSInactive
Code: I4807BK602Class: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULRClass: IACT
© Copyright 2025. All Rights Reserved by MedPath